NTI 1.45% 7.0¢ neurotech international limited

NTI will soon double in shareprice!, page-46

  1. 1,528 Posts.
    lightbulb Created with Sketch. 89
    Hey guys

    So I am looking to put some questions to NTI management to further de-risk entry into NTI and I have some rough questions which need polishing and would love your input.

    Can you please review my questions and add more or alternatively help refine the questions I currently have.

    They are:

    1. Upon publication of NTI’s double blind results (if positive) is NTI going to start an immediate marketing/ advertising campaign to notify the market of the positive results and unique benefits of the ‘in-home’ Mente autism device? If so, what will the marketing/ advertising drive look like and will it include large target markets such as Europe and the USA?
    2. Is it expected around the same period of the double blind results announcement that the UK distribution agreement will be additionally signed and announced to the market?
    3. How will the results of the double blind study (if successful) be utilised to speed up direct sales of the Mente autism device to target customers?
    4. How will the double blind results (if positive) be used to drive penetration into target countries and distribution channels?

    Your input on these questions before I put them to NTI management would be fantastic.

    Thanks

    bruutz82
    Last edited by bruutz82: 04/12/17
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.001(1.45%)
Mkt cap ! $64.55M
Open High Low Value Volume
7.1¢ 7.1¢ 7.0¢ $16.67K 237.0K

Buyers (Bids)

No. Vol. Price($)
3 75250 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 23082 1
View Market Depth
Last trade - 14.13pm 28/11/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.